Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 5.238.608.177.076.05

What is the latest Working Capital/Sales ratio of PIRAMAL PHARMA ?

The latest Working Capital/Sales ratio of PIRAMAL PHARMA is 5.23 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20255.23
Mar20248.60
Mar20238.17
Mar20227.07
Mar20216.05

How is Working Capital/Sales of PIRAMAL PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 5.23
-39.19
Mar2024 8.6
5.26
Mar2023 8.17
15.56
Mar2022 7.07
16.86
Mar2021 6.05 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Working Capital/Sales ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹26,863.1 Cr 2.5% 3.5% -6.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,804.0 Cr -0.2% 3.6% -7.8% Stock Analytics
DIVIS LABORATORIES ₹170,764.0 Cr -2.4% 9.1% 13.4% Stock Analytics
CIPLA ₹126,807.0 Cr -5.7% 4% 6.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,099.0 Cr -0.3% 1.3% 8.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,707.0 Cr 0.1% 1.2% -2.8% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

2.5%

3.5%

-6.2%

SENSEX

0.3%

3.6%

5.5%


You may also like the below Video Courses